지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Journal of the Korean Surgical Society Vol.85 No.4
- 발행연도
- 2013.10
- 수록면
- 185 - 190 (6page)
이용수
초록· 키워드
오류제보하기
Purpose: To evaluate the optimum timing of aspirin cessation before noncardiac surgeries. We have conducted a pilot study to minimize the aspirin cessation time before various surgeries.
Methods: Eighty patients who were taking regular aspirin for secondary prevention undergoing elective surgical operations were enrolled in the study. We separated the patients into two groups. The control group had 35 patients who stopped aspirin intake 10 days before surgery. The study group had 45 patients who stopped their aspirin intake and underwent surgery one day after arachidonic acid aggregation tests were within normal limits. Bleeding, blood loss, and transfusion requirements were assessed perioperatively.
Results: The mean time between aspirin cessation and aspirin nonresponsiveness were found to be 4.2 days with a median value of 4 days. In addition, the mean time between aspirin cessation and operation day were found to be 5.5 days with a median value of 5 days. No perioperative bleeding, thromboembolic or cardiovascular complications were encountered.
Conclusion: Reducing time of aspirin cessation from 7-10 days to 4-5 days is a possibility for patients using aspirin for secondary prevention without increased perioperative complications.
Methods: Eighty patients who were taking regular aspirin for secondary prevention undergoing elective surgical operations were enrolled in the study. We separated the patients into two groups. The control group had 35 patients who stopped aspirin intake 10 days before surgery. The study group had 45 patients who stopped their aspirin intake and underwent surgery one day after arachidonic acid aggregation tests were within normal limits. Bleeding, blood loss, and transfusion requirements were assessed perioperatively.
Results: The mean time between aspirin cessation and aspirin nonresponsiveness were found to be 4.2 days with a median value of 4 days. In addition, the mean time between aspirin cessation and operation day were found to be 5.5 days with a median value of 5 days. No perioperative bleeding, thromboembolic or cardiovascular complications were encountered.
Conclusion: Reducing time of aspirin cessation from 7-10 days to 4-5 days is a possibility for patients using aspirin for secondary prevention without increased perioperative complications.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (19)
참고문헌 신청
1. [학술지(정기간행물)] - Jambor C / 2009 / Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction / Anesth Analg 109 : 25 ~ 31
2. [학술지(정기간행물)] - Toth O / 2006 / Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood / Thromb Haemost 96 : 781 ~ 788
3. [학술지(정기간행물)] - US Preventive Services Task Force / 2009 / Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement / Ann Intern Med 150 : 396 ~ 404
4. [학술지(정기간행물)] - Hall R / 2011 / Antiplatelet drugs: a review of their pharmacology and management in the perioperative period / Anesth Analg 112 : 292 ~ 318
5. [학술지(정기간행물)] - Antithrombotic Trialists’ (ATT) Collaboration / 2009 / Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials / Lancet 373 : 1849 ~ 1860
2. [학술지(정기간행물)] - Toth O / 2006 / Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood / Thromb Haemost 96 : 781 ~ 788
3. [학술지(정기간행물)] - US Preventive Services Task Force / 2009 / Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement / Ann Intern Med 150 : 396 ~ 404
4. [학술지(정기간행물)] - Hall R / 2011 / Antiplatelet drugs: a review of their pharmacology and management in the perioperative period / Anesth Analg 112 : 292 ~ 318
5. [학술지(정기간행물)] - Antithrombotic Trialists’ (ATT) Collaboration / 2009 / Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials / Lancet 373 : 1849 ~ 1860
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2014-510-002804999